Kidney transplantation in the patient with hepatitis C virus infection

Contributions to Nephrology

Volumn 176, Issue , 2012, Pages 77-86

  Morales, Jose M ^a   Bloom, Roy ^b   Roth, David ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE;

DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSION; INFECTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS;

EID: 84856811988     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000332385     Document Type: Article

References (36)

1. Pereira BJ, Levey AS: Hepatitis C virus infec-tion in dialysis and renal transplantation. Kidney Int 1997;51:981-999. (Pubitemid 27186522)
2. Roth D: Hepatitis C virus: the nephrologist's view. Am J Kidney Dis 1995;25:3-16.
3. Morales JM, Campistol JM: Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000;11:1343-1353. (Pubitemid 30416233)
4. European Best Practice Guidelines for Renal Transplantation. Section I: Evaluation, selec-tion and preparation of the potential recipi-ent. Nephrol Dial Transplant 2000;15(suppl 7):3-38.
5. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2008;73(suppl 109):S1-S99.
6. Morales JM, Dominguez-Gil B, Sanz-Guajardo D, et al: The influence of hepatitis B and hepatitis C virus infection in the recip-ient on late renal allograft failure. Nephrol Dial Transplant 2004;19(supply 3):72-76.
7. Burra P Buda A, Livi U, et al: Occurrence of post-transplant lymphoproliferative disor-ders among over thousand adult recipients: any role for hepatitis C infection? Eur J Gastroenterol Hepatol 2006;18:1065-1070. (Pubitemid 44379359)
8. Caillard S, Lelong C, Pessione F, Moulin B: Post-transplant lymphoproliferative disor-ders occurring after renal transplantation in adults: report of 230 cases from the French Registry Am J Transplant 2006;6:2735-4227.
9. Caillard S, Agodoa LY, Bohen EM, Abbott KC: Myeloma, Hodgkin disease and lym-phoid leukaemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation 2006;27:888-895.
10. Corell A, Morales JM, Mandroño A, et al: Immunosuppression induced by hepatitis C virus infection reduces acute renal transplant rejection. Lancet 1995;346:1497-1498.
11. Roth D, Gaynor JJ, Reddy KR, et al: Clinical outcomes in hepatitis C patients before and after kidney transplantation. J Am Soc Nephrol 2011;22:1152-1160.
12. Forman JP Tolkoff-Rubin N, Pascual M, Lin J: Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 2004;15:3249-3255. (Pubitemid 39578858)
13. Morales JM, Marcen R, Andres A, et al: Renal transplantation in patients with hepa-titis C virus antibody A long national experi-ence. NDT Plus 2010;3(suppl 2):ii41-ii46.
14. Moreso F, Ibernon M, Goma M, et al: Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006;6:747-752. (Pubitemid 43345012)
15. Rao KV, Ma J: Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996;62:1765-1769. (Pubitemid 27014534)
16. Mitwalli AH, Alam A, Al-Wakeel J, et al: Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract 2006;102:c72-c80. (Pubitemid 43087564)
17. Lopez Medrano F, Fernandez M, Morales JM, et al: Impact of hepatitis C virus infec-tion on the risk of infectious complications after kidney transplantation. Data from the RESITRA/REIPI cohort. Transplantation 2011;92:543-549.
18. Torres J, Aguado JM, San Juan R, et al: Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transplant Int 2008;21:873-878.
19. Bloom RD, Sayer G, Fa K, et al: Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005;5:139-144. (Pubitemid 40095138)
20. Abbott KC, Bucci JR, Matsumoto CS, et al: Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003;14:2908-2918. (Pubitemid 37309327)
21. Campbell MS, Constantinescu S, Furth EE, Reddy KR, Bloom RD: Effects of hepati-tis C-induced liver fibrosis on survival in kidney transplant candidates. Dig Dis Sci 2007;52:2501-2507. (Pubitemid 47373906)
22. Scott DR, Wong JKW, Spicer TS, et al: Adverse impact of hepatitis C virus infec-tion on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation 2010;90:1165-1171.
23. Dominguez-Gil B, Morales JM: Transplantation in the patient with hepatitis C. Transplant Int 2009;22:1117-1131.
24. Legendre C, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P Kreis H, Pol S: Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998;65:667-670. (Pubitemid 28128936)
25. Mathurin P, Mouquet C, Poynard T, et al: Impact of hepatitis B and C virus on kid-ney transplantation outcome. Hepatology 1999;29:257-263. (Pubitemid 29024011)
26. Maluf DG, Fisher RA, King AL, et al: Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 2007;83:853-857. (Pubitemid 46682725)
27. Fabrizi F, Martin P Dixit V, Bunnapradist S, Dulai G: Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005;5:1452-1461. (Pubitemid 40839438)
28. Knoll GA, Tankersley MR, Lee JY, et al: The impact of renal transplantation on survival in hepatitis C positive end-stage renal dis-ease patients. Am J Kidney Dis 1997;29:606-614.
29. Pereira BJ, Natov SN, Bouthot, et al: Effects of hepatitis C infection and renal transplan-tation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53:1374-1381. (Pubitemid 28316901)
30. Wolfe RA, Ashby VB, Milford El, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting trans-plantation and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-1730.
31. Bruchfeld A, Wilczek H, Einder CG: Hepatitis C infection, time in renal-replacement therapy and outcome after kidney transplantation. Transplantation 2004;78:745-750. (Pubitemid 39244740)
32. Gentil MA, Rocha JL, Rodriguez Algarra G, et al: Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999;94:2455-2460. (Pubitemid 29462486)
33. Mahmoud IM, Elhabasi AF, Elsawy E, et al: The impact of hepatitis C virus vire-mia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 2004;43:131-139. (Pubitemid 38049444)
34. Lin HH, Huang CC, Huang JY, et al: Impact of HCV infection on first cadaveric renal transplantation, a single center experience. Clin Transplant 2004;18:261-266.
35. Hestin D, Guillemin F, Castin N, et al: Pre-transplant hepatitis C virus infection: a predictor of proteinuria after renal transplan-tation. Transplantation 1998;65:741-744. (Pubitemid 28128949)
36. Cosio FG, Roche Z, Agrawal A, et al: Prevalence of hepatitis C virus in patients with idiopathic glomerulopathies in native and transplanted kidneys. Am J Kidney Dis 1996;28:752-758. (Pubitemid 26363905)